Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections

Publication date

2020-04

Authors

Van Hensbergen, Vincent P.
Wu, Yongzheng
van Sorge, NinaISNI 000000039584948X
Touqui, Lhousseine

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

The enzyme type IIA secreted phospholipase A2 (sPLA2-IIA) is crucial for mammalian innate host defense against bacterial pathogens. Most studies have investigated the role of sPLA2-IIA in systemic bacterial infections, identifying molecular pathways of bacterial resistance against sPLA2-IIA-mediated killing, and providing insight into sPLA2-IIA mechanisms of action. Sensitization of (antibiotic-resistant) bacteria to sPLA2-IIA action by blocking bacterial resistance or by applying sPLA2-IIA to treat bacterial infections might represent a therapeutic option in the future. Because sPLA2-IIA is highly expressed at mucosal barriers, we also discuss how sPLA2-IIA is likely to be an important driver of microbiome composition; we anticipate that future research in this area may bring new insights into the role of sPLA2-IIA in health and disease.

Keywords

antimicrobial enzyme, bacteria, infections, microbiome, phospholipase, virulence, Taverne, Immunology and Allergy, Immunology, Review, Journal Article

Citation

van Hensbergen, V P, Wu, Y, van Sorge, N M & Touqui, L 2020, 'Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial Infections', Trends in immunology, vol. 41, no. 4, pp. 313-326. https://doi.org/10.1016/j.it.2020.02.003